CAS: 412950-27-7 - Goxalapladib
Formula:C40H39F5N4O3
- Synonyms:
- 2-[2-(2,3-Difluorophenyl)ethyl]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1,8-naphthyridine-1(4H)-acetamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Goxalapladib REF: 3D-FG104321CAS: 412950-27-7 | Min. 95% | To inquire | Tue 10 Dec 24 |
 | Goxalapladib REF: TM-T67799CAS: 412950-27-7 | 99.41% - 99.95% | 182.00 €~1,384.00 € | Wed 15 Jan 25 |
Goxalapladib
CAS:412950-27-7
Goxalapladib is a recombinant protein that stimulates homologous recombination, which is the repair of double-stranded …
Formula:
C40H39F5N4O3
Purity:
Min. 95%
Molecular weight:
718.75 g/mol
Ref: 3D-FG104321
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Goxalapladib
CAS:412950-27-7
Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks …
Formula:
C40H39F5N4O3
Purity:
99.41% - 99.95%
Color and Shape:
Liquid
Molecular weight:
718.75
Ref: TM-T67799
| 1mg | 182.00 € | ||
| 5mg | 449.00 € | ||
| 10mg | 643.00 € | ||
| 25mg | 1,009.00 € | ||
| 50mg | 1,384.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
